<DOC>
	<DOCNO>NCT01564706</DOCNO>
	<brief_summary>This study determine florbetapir F 18 ( 18F-AV-45 ) radioactivity distribute throughout body .</brief_summary>
	<brief_title>A Study 18F-AV-45 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Able lie still image table period 1 hour Radiation exposure experimental purpose within last year Claustrophobic otherwise unable tolerate imaging procedure Medical condition surgical history would confound evaluation Current clinically significant cardiovascular disease Received investigational medication within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Amyloid imaging</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>18F-AV-45</keyword>
	<keyword>florbetapir F 18</keyword>
	<keyword>Diagnostic imaging</keyword>
</DOC>